Mortality risk increased for MS patients soon after CRC diagnosis
Sep 16, 2021
Associations between MS and all-cause, cancer-specific death partially attenuated after adjustment for disability status
MS drug Tecfidera approved, awaited
By
Kevin McCaffrey
May 01, 2013
The approval of Biogen Idec’s MS therapy Tecfidera follows months of breathless Wall Street hype, and it looks like doctors are psyched for the drug, too. In a MedLIVE PULSE survey conducted by WorldOne...